{"title":"Predicting human pharmacokinetics from preclinical data: volume of distribution.","authors":"Dong-Seok Yim, Suein Choi","doi":"10.12793/tcp.2020.28.e19","DOIUrl":null,"url":null,"abstract":"<p><p>This tutorial introduces background and methods to predict the human volume of distribution (V<sub>d</sub>) of drugs using <i>in vitro</i> and animal pharmacokinetic (PK) parameters. The physiologically based PK (PBPK) method is based on the familiar equation: <i>V<sub>d</sub></i> = <i>V<sub>p</sub></i> + ∑ <i><sub>T</sub></i> (<i>V<sub>T</sub></i> × <i>k<sub>tp</sub></i> ). In this equation, V<sub>p</sub> (plasma volume) and V<sub>T</sub> (tissue volume) are known physiological values, and k<sub>tp</sub> (tissue plasma partition coefficient) is experimentally measured. Here, the k<sub>tp</sub> may be predicted by PBPK models because it is known to be correlated with the physicochemical property of drugs and tissue composition (fraction of lipid and water). Thus, PBPK models' evolution to predict human V<sub>d</sub> has been the efforts to find a better function giving a more accurate k<sub>tp</sub>. When animal PK parameters estimated using i.v. PK data in ≥ 3 species are available, allometric methods can also be used to predict human V<sub>d</sub>. Unlike the PBPK method, many different models may be compared to find the best-fitting one in the allometry, a kind of empirical approach. Also, compartmental V<sub>d</sub> parameters (e.g., V<sub>c</sub>, V<sub>p</sub>, and Q) can be predicted in the allometry. Although PBPK and allometric methods have long been used to predict V<sub>d</sub>, there is no consensus on method choice. When the discrepancy between PBPK-predicted V<sub>d</sub> and allometry-predicted V<sub>d</sub> is huge, physiological plausibility of all input and output data (e.g., r<sup>2</sup>-value of the allometric curve) may be reviewed for careful decision making.</p>","PeriodicalId":23288,"journal":{"name":"Translational and Clinical Pharmacology","volume":"28 4","pages":"169-174"},"PeriodicalIF":1.1000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a8/9d/tcp-28-169.PMC7781809.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational and Clinical Pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12793/tcp.2020.28.e19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/12/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
This tutorial introduces background and methods to predict the human volume of distribution (Vd) of drugs using in vitro and animal pharmacokinetic (PK) parameters. The physiologically based PK (PBPK) method is based on the familiar equation: Vd = Vp + ∑ T (VT × ktp ). In this equation, Vp (plasma volume) and VT (tissue volume) are known physiological values, and ktp (tissue plasma partition coefficient) is experimentally measured. Here, the ktp may be predicted by PBPK models because it is known to be correlated with the physicochemical property of drugs and tissue composition (fraction of lipid and water). Thus, PBPK models' evolution to predict human Vd has been the efforts to find a better function giving a more accurate ktp. When animal PK parameters estimated using i.v. PK data in ≥ 3 species are available, allometric methods can also be used to predict human Vd. Unlike the PBPK method, many different models may be compared to find the best-fitting one in the allometry, a kind of empirical approach. Also, compartmental Vd parameters (e.g., Vc, Vp, and Q) can be predicted in the allometry. Although PBPK and allometric methods have long been used to predict Vd, there is no consensus on method choice. When the discrepancy between PBPK-predicted Vd and allometry-predicted Vd is huge, physiological plausibility of all input and output data (e.g., r2-value of the allometric curve) may be reviewed for careful decision making.
期刊介绍:
Translational and Clinical Pharmacology (Transl Clin Pharmacol, TCP) is the official journal of the Korean Society for Clinical Pharmacology and Therapeutics (KSCPT). TCP is an interdisciplinary journal devoted to the dissemination of knowledge relating to all aspects of translational and clinical pharmacology. The categories for publication include pharmacokinetics (PK) and drug disposition, drug metabolism, pharmacodynamics (PD), clinical trials and design issues, pharmacogenomics and pharmacogenetics, pharmacometrics, pharmacoepidemiology, pharmacovigilence, and human pharmacology. Studies involving animal models, pharmacological characterization, and clinical trials are appropriate for consideration.